Pharma

August 26, 2021, 5:53 pm

Venus Remedies is a pharmaceutical conglomerate that is research-driven, with an outstanding global presence. Since the year 2004, Venus Remedies has played a pivotal role in research related to infectious diseases in India. The company is based out of Baddi in Himachal Pradesh and has a global presence in over 70 countries. Venus Remedies also manages a team of over a... Read More

Categories:
August 6, 2021, 4:41 pm

Cell Source Inc. announced that they have received two patents for their Veto Cell Technology, which has been issued by the United States Patent and Trademark Office (USPTO). The first patent is the “Veto Cells Generated from Memory T Cells” and the second patent is the “Method of Transplantation and Disease Treatment.”... Read More

June 24, 2021, 5:14 pm

A patent infringement suit has been filed by Panacea Biotech Limited before the Delhi High Court for restraining Sanofi Healthcare India Pvt. Ltd. from marketing Hexavalent vaccine which will infringe Panacea’s patent for its fully liquid Whole-Cell Pertussis based fully liquid Hexavalent Vaccine,... Read More

June 21, 2021, 5:30 pm

The United States Patent Office issues a patent for a wearable artificial kidney to Nephrologists Victor Gura, MD, Chairman and Chief Scientific Officer of Wearable Artificial Organs Inc. The clinical trial is expected to start this year to test the third-generation device. The Patentee Gura is an... Read More

May 26, 2021, 9:01 am

For a business, the development of IP is an important part but more important is the efficient management of IP in the business. The business considers the IP as a strong asset for it and hence it is imperative to have a strong strategic portion for the IP to maximize the profit-making part. In the field of Healthcare and its greater reliance on the aspects of AI and... Read More

March 26, 2021, 9:05 am

The decision of the Controller of Patent to revoke Novartis’ patent on the anti-cancer drug Ceritinib, was quashed by the Intellectual Property Appellate Board (IPAB). This decision examines several issues concerning the novelty and obviousness, the extent of coverage and disclosure, and timelines for filing the evidence. The IPAB while quashing the decision held that... Read More

February 5, 2021, 9:47 am

The IP was never an important part of any international agreement even after the enforcement of GATT. Even in various bilateral and multilateral treaty agreements, IP was never a subject for negotiations. The greater reliance on the contribution of technology and international trade moving at a faster pace have made IP, the central point of all the agreements, be it... Read More

January 30, 2021, 10:20 am

The latest case of Horizon Pharma vs. Dr. Reddy touches upon an important aspect of drafting the specification and indefiniteness in the US Patent Law. 35 U.S.C. § 112(b), which says that the specification shall conclude with one or more claims particularly pointing out and distinctly claiming the... Read More

January 13, 2021, 10:04 am

Patent Ever-greening has been largely used by the pharmaceutical industry for extending their patent protection. Industries generally use various legal and technological strategies to extend the term. Establishing or partnering with the generic establishment are some external strategies being used by the industries. But the majorly used strategy is the intentional minor... Read More

Categories:
January 12, 2021, 10:13 am

The denial of the market entry often concerns the access to essential and cheaper medicines and in a larger picture, the public health issue. The availability of generic drugs being subjected to any such preceding condition irrespective of any infringement does affect the larger issues of access to medicine. Patent linkage is perhaps one of the most debatable aspects of... Read More

Pages